ASPPH logo

Connect

Partner News

Partner News

DHHS Funding Opportunities

FUNDING OPPORTUNITIES from the Department of Health and Human Services (DHHS)

________________________________________________________

Department of Health and Human Services – Health Resources and Services Administration – Ryan White HIV/AIDS Program Part C Capacity Development Program

Proposal Due Date: February 19, 2021

Expected Number of Awards: 60

Estimated Total Program Funding: $8,000,000

Award Ceiling:

Award Floor:

Funding Opportunity Number: HRSA-21-058

Purpose: This notice announces the opportunity to apply for funding under the Health Resources and Services Administration’s (HRSA) Ryan White HIV/AIDS Program (RWHAP) Part C Capacity Development Program. The purpose of this program is to strengthen organizational capacity to respond to the changing health care landscape and increase access to high-quality HIV primary health care services for low-income, uninsured, and underserved people with HIV.

Funding under this program is intended to support one short-term activity that can be completed by the end of the one-year period of performance. You may propose an expansion of an activity previously supported under FY2019 or FY2020 RWHAP Part D Supplemental (HRSA-19-026; HRSA-20-068) or Part C Capacity Development funding (HRSA-19-031; HRSA-20-067) however, HRSA will not fund the same activity in FY 2021 as HRSA funded previously in FY 2019 or FY 2020. If the proposed project is an expansion of a previously funded activity, you will be required to provide a clear rationale for how the proposed activity builds upon and furthers the objectives of the previously funded HIV Care Innovation or Infrastructure Development activity.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Alzheimer’s Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)

Letter of Intent Due Date: January 5, 2021

Proposal Due Date: February 5, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-20-309

Purpose: This Funding Opportunity Announcement (FOA) invites applications to develop and implement Phase Ib to III clinical trials of promising pharmacological and non-pharmacological interventions that may prevent, delay, or treat the symptoms of Alzheimer’s disease (AD) and other age-related dementias using the Alzheimer’s disease Clinical Trials Consortium (ACTC) trial coordination and management infrastructure.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)

Proposal Due Date: February 16, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-21-084

Purpose: The NIDCR Small Grant Program for New Investigators (R03) supports basic and clinical research conducted by scientists who are in the early stages of establishing an independent research career in oral, dental and craniofacial research. This program supports pilot or feasibility studies and developmental research projects with the intention of obtaining sufficient preliminary data for a subsequent investigator-initiated Research Project Grant (R01) or equivalent application.

The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. This program will support small pilot or feasibility studies and developmental research projects with the intention of obtaining sufficient preliminary data to support the subsequent submission of a competitive investigator-­initiated R01 or equivalent research application. This FOA may not be used to support clinical trials.. Individuals proposing clinical trials must use the UG3/UH3 mechanism. The R03 is not intended to sustain research careers; rather, it is expected that New Investigators will use this award to provide a foundation to facilitate future success in achieving long term R01 or equivalent grant funding.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: February 21, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling: $150,000

Award Floor:

Funding Opportunity Number: RFA-CA-21-007

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI R01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the adoption of these emerging technologies by appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: February 21, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling: $150,000

Award Floor:

Funding Opportunity Number: RFA-CA-21-008

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI U01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: February 21, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: RFA-CA-21-009

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI U54 Resource-Related Research Projects. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: February 21, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: RFA-CA-21-010

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI U2C Resource-Related Multi-Component Projects and Centers. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: February 21, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: RFA-CA-21-011

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI P01 program projects. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: February 21, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: RFA-CA-21-012

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI P50 specialized centers. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: March 10, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: RFA-CA-21-001

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses. Both small businesses and universities are drivers of technological innovation in the United States (U.S.), often working together to advance innovative ideas into products that can benefit the U.S. population. While most NIH funding supports basic research in university laboratories, the NIH also supports innovative technology development in U.S. small businesses through its SBIR STTR programs. As technologies transition from academic discovery to small businesses, two common challenges arise, identifying the right team with the right expertise to take the product into a small business, and funding for early-stage technology development. This FOA seeks to address both challenges simultaneously by having two equally important goals; entrepreneurial mentoring support, and product development support.

View more details on this opportunity.

 

Department of Health and Human Services – Administration for Community Living – 2021 Integrated Networks to Deliver and Sustain Evidence-Based Chronic Disease Self-Management Education Programs

Proposal Due Date: February 2, 2021

Expected Number of Awards: 3

Estimated Total Program Funding: $4,130,440

Award Ceiling: $1,400,000

Award Floor: $1,100,000

Funding Opportunity Number: HHS-2021-ACL-AOA-CSSG-0014

Purpose: This funding opportunity has two goals:

Goal 1: Strengthen integrated state, regional, or tribal networks that address the social and behavioral determinants of health of older adults and adults with disabilities.

Goal 2: Significantly increase the number of older adults and adults with disabilities who participate in chronic disease self-management education and self-management support programs.

View more details on this opportunity.

 

Department of Health and Human Services – Administration for Community Living – 2021 Empowering Communities to Reduce Falls and Falls Risk

Proposal Due Date: February 2, 2021

Expected Number of Awards: 6

Estimated Total Program Funding: $1,725,304

Award Ceiling: $300,000

Award Floor: $200,000

Funding Opportunity Number: HHS-2021-ACL-AOA-FPSG-0015

Purpose: This funding opportunity has two goals:

Goal 1: Through robust partnerships, develop a result-based, comprehensive strategy for reducing falls and falls risk among older adults and adults with disabilities living in your community.

Goal 2: Significantly increase the number of older adults and adults with disabilities who participate in evidence-based falls prevention programs, while concurrently pursuing the sustainability of these programs beyond the end of the grant period.

View more details on this opportunity.

 

Department of Health and Human Services – Administration for Community Living – 2021 Integrated Networks to Deliver and Sustain Evidence-Based Falls Prevention Programs

Proposal Due Date: February 2, 2021

Expected Number of Awards: 2

Estimated Total Program Funding: $2,200,000

Award Ceiling: $1,100,000

Award Floor: $700,000

Funding Opportunity Number: HHS-2021-ACL-AOA-FPSG-0017

Purpose: This funding opportunity has two goals:

Goal 1: Strengthen integrated state, regional, or tribal networks that address the social and behavioral determinants of health of older adults and adults with disabilities.

Goal 2: Significantly increase the number of older adults and adults with disabilities who participate in evidence-based community programs to reduce falls and falls risk.

View more details on this opportunity.

 

Department of Health and Human Services – Administration for Community Living – 2021 Empowering Communities to Address Behavioral Health and Chronic Pain through Chronic Disease Self-Management Education Programs

Proposal Due Date: February 2, 2021

Expected Number of Awards: 8

Estimated Total Program Funding: $2,000,000

Award Ceiling: $300,000

Award Floor: $200,000

Funding Opportunity Number: HHS-2021-ACL-AOA-CSSG-0018

Purpose: This funding opportunity has two goals:

Goal 1: Through robust partnerships, develop a result-based, comprehensive strategy for addressing behavioral health and/or chronic pain among older adults and adults with disabilities living in your community.

Goal 2: Significantly increase the number of older adults and adults with disabilities who participate in evidence-based self-management education and/or self-management support programs to empower them to better manage these chronic condition(s), while concurrently pursuing the sustainability of these programs beyond the end of the grant period.

View more details on this opportunity.

 

Department of Health and Human Services – Administration for Community Living – 2021 Integrated Networks to Deliver and Sustain Evidence-Based Chronic Disease Self-Management Education Programs

Proposal Due Date: February 2, 2021

Expected Number of Awards: 3

Estimated Total Program Funding: $4,130,440

Award Ceiling: $1,400,000

Award Floor: $1,100,000

Funding Opportunity Number: HHS-2021-ACL-AOA-CSSG-0014

Purpose: This funding opportunity has two goals:

Goal 1: Strengthen integrated state, regional, or tribal networks that address the social and behavioral determinants of health of older adults and adults with disabilities.

Goal 2: Significantly increase the number of older adults and adults with disabilities who participate in chronic disease self-management education and self-management support programs.

View more details on this opportunity.

 

Department of Health and Human Services – Administration for Community Living – Small Business Innovation Research Program (SBIR) Phase I

Proposal Due Date: February 2, 2021

Expected Number of Awards: 10

Estimated Total Program Funding: $1,000,000

Award Ceiling: $100,000

Award Floor: $95,000

Funding Opportunity Number: HHS-2021-ACL-NIDILRR-BISA-0033

Purpose: The purpose of the Federal SBIR program is to stimulate technological innovation in the private sector, strengthen the role of small business in meeting Federal research or research and development (R/R&D) needs, and improve the return on investment from Federally-funded research for economic and social benefits to the Nation.  The specific purpose of NIDILRR’s SBIR program is to improve the lives of people with disabilities through R/R&D products generated by small businesses, and to increase the commercial application of NIDILRR-supported research results and development products.

View more details on this opportunity.

 

Department of Health and Human Services – Centers for Disease Control – NCCDPHP – Tobacco Prevention and Control-Related Public Health Law Technical Assistance

Proposal Due Date: March 1, 2021

Expected Number of Awards: 1

Estimated Total Program Funding: $1,925,000

Award Ceiling: $385,000

Award Floor: $235,000

Funding Opportunity Number: CDC-RFA-DP21-2103

Purpose: The Centers for Disease Control and Prevention’s Office on Smoking and Health (OSH) provides funding and support for the National Tobacco Control Program (NTCP). The goals of OSH and the NTCP are to use evidence-based policies, systems, and environmental (PSE) changes to prevent initiation among youth; reduce exposure to secondhand smoke; promote quitting among adults and youth, and identify and eliminate tobacco-related disparities.

This funding opportunity will ensure NTCP recipients and their partners have access to specific, timely technical assistance from highly knowledgeable public health law experts in order to implement the strategies proven to reduce morbidity and mortality due to tobacco use. An awareness of public health law can 1) inform NTCP recipients and their partners as they identify, develop, and implement evidence-based PSE changes; and 2) provide technical assistance on public health law as it relates to tobacco control is crucial for achieving program goals. This funding opportunity builds on the successes of CDC-RFA-DP16-1610, Tobacco Prevention and Control Related Public Health Law Technical Assistance.

National access to technical assistance also assures that all programs, regardless of geographic location or organizational resources, have tailored, tobacco control-specific expertise available to support their efforts. Note: Public health law technical assistance should not be construed as legal advice and does NOT replace an NTCP recipient or partner organization’s own counsel or legal advice.

View more details on this opportunity.

Department of Health and Human Services – Centers for Disease Control – ERA – Reducing Inequities in Cancer Outcomes through Community-Based Interventions on Social Determinants of Health

Proposal Due Date: March 15, 2021

Expected Number of Awards: 3

Estimated Total Program Funding: $15,000,000

Award Ceiling: $1,000,000

Award Floor:

Funding Opportunity Number: RFA-DP-21-003

Purpose: The purpose of this NOFO is to conduct evaluation research to build an evidence base of innovative, community-based interventions across multiple domains of social determinants of health to reduce racial and ethnic disparities in cancer outcomes. Evaluation research is defined as the systematic application of public health research procedures for assessing the conceptualization, design, implementation, effectiveness and utility of public health interventions. This research would advance our understanding of what works, for whom and why.

Component A: Primary Cancer Prevention – to conduct evaluation research on an innovative, multi-sector intervention to reduce cancer risk in one or more socially or economically disadvantaged populations. This research will examine the implementation, impact, and causal mechanisms of the intervention’s effect to reduce cancer risk at the population level.

Component B: Cancer Screening – to conduct evaluation research on an innovative, multi-sector intervention to reduce inequities in the receipt of appropriate screening services (on-time initial screening, routine re-screening at recommended intervals, appropriate follow-up after inconclusive/incomplete screening) among one or more socially or economically disadvantaged populations. This research will generate knowledge about the implementation, impact, and causal mechanisms of the intervention’s effect on cancer screening outcomes.

Component C: Health and Wellbeing of Cancer Survivors – to conduct evaluation research on an innovative, multi-sector intervention to address barriers to health and well-being among cancer survivors from one or more socially or economically disadvantaged populations. This research will generate knowledge about the implementation, impact, and causal mechanisms of the intervention’s effect on the health and wellbeing of cancer survivors.

Applicants may apply for one Component (Component A or Component B or Component C).

View more details on this opportunity.

 

Department of Health and Human Services – Centers for Disease Control – NCCDPHP – Strengthening Breastfeeding Support by Coordinating National Efforts and Building Capacity of Breastfeeding Coalitions

Proposal Due Date: March 15, 2021

Expected Number of Awards: 1

Estimated Total Program Funding: $5,000,000

Award Ceiling: $1,000,000

Award Floor: $600,000

Funding Opportunity Number: CDC-RFA-DP21-2108

Purpose: CDC intends to award one Cooperative Agreement pursuant to this notice of funding opportunity. Subject to funding availability and at the discretion of the Agency, CDC intends to provide up to $5-10 million in total CDC funding over a five (5) year period.  Applicants will be required to have documented affiliations with state-level breastfeeding coalitions in all states (or U.S. territories) to perform the objectives and goals of this Notice.

This activity will help to reduce health gaps related to breastfeeding caused by differences such as income, education, race/ethnicity and location. This activity will complement current CDC breastfeeding activities and build on previous experiences and successes, while incorporating new sustainable approaches that promote optimal breastfeeding support.

The purposes of this opportunity are to improve breastfeeding initiation, duration and exclusivity and to decrease racial/ethnic disparities in breastfeeding by coordinating a national approach which engages state-level breastfeeding coalitions in all states (or U.S. territories) to do the following:

1) Coordinate and develop a five year action and implementation plan for policy, systems, and environmental changes to address breastfeeding inequities and increase access to breastfeeding support.

2) Enhance opportunities for collaboration among state-level breastfeeding coalitions with respect to associated activities.

3) Develop and disseminate, recommendations and resources to address infant and young child feeding in emergencies and barriers to breastfeeding to help mothers attain their breastfeeding goals.

4) Support partnerships with governmental agencies, medical organizations, and other national organizations that are promoting, investing in, or developing guidance or recommendations for breastfeeding support.

5) Increase clinicians’ adoption and utilization of maternity practices supportive of breastfeeding, and CDC guidance related to continuity of care in breastfeeding.

View more details on this opportunity.

 

Department of Health and Human Services – Health Resources and Services Administration – Fiscal Year 2021 Ending the HIV Epidemic – Primary Care HIV Prevention

Proposal Due Date: February 2, 2021

Expected Number of Awards: 300

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: HRSA-21-092

Purpose: Fiscal year (FY) 2021 Ending the HIV Epidemic – Primary Care HIV Prevention (PCHP) will make funding available on a competitive basis to a subset of Health Center Program award recipients to expand the number of health centers funded to focus on HIV prevention in the initiative-targeted areas (195 received FY 2020 PCHP supplemental funding (HRSA-20-091) in March 2020). FY 2021 award recipients  will leverage their comprehensive primary care experience and build and/or strengthen their HIV prevention capacity to support increases in HIV testing, pre-exposure prophylaxis (PrEP) prescriptions, and linkage to HIV care and treatment.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – NHLBI Program Project Applications (P01 Clinical Trials Optional)

Letter of Intent Due Date: 60 days prior to application due date

Proposal Due Date: January 25, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-21-088

Purpose: This Funding Opportunity Announcement (FOA), issued by the National Heart, Lung, and Blood Institute (NHLBI) invites submission of investigator-initiated Program Project (P01) applications. The proposed programs may address scientific areas relevant to the NHLBI mission including the biology and diseases of the heart, blood vessels, lung, and blood; blood resources; and sleep disorders. Programs may also include implementation science, health disparities, and translation research that addresses the mission of the Institute. Each application submitted in response to this FOA must include at least three related research projects that share a common central theme, focus, and/or overall objective. Higher budgets may be requested for applications that include at least four projects, one of which includes an Early Stage Investigator as Project Leader.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trials Not Allowed)

Proposal Due Date: February 16, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-21-090

Purpose: The Office of Research Infrastructure Programs (ORIP) within the Division of Program Coordination, Planning, and Strategic Initiatives announces an opportunity to apply for small grant support for ORIP-supported Special Emphasis Research Career Award (SERCA) K01 recipients who have completed the first two years (24 months) of the SERCA K01 award. ORIP seeks to enhance the ability of ORIP SERCA K01 awardees to conduct research as they transition to fully independent investigator status. The R03 mechanism supports projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is intended to support research projects that can realistically be completed in two years and that require limited levels of funding. This Funding Opportunity Announcement does not accept applications proposing clinical trial(s).

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Summer Institute for Research Education in Biostatistics and Data Science (R25 Clinical Trial Not Allowed)

Letter of Intent Due Date: February 8, 2021

Proposal Due Date: March 8, 2021

Expected Number of Awards: 7

Estimated Total Program Funding: $1,807,720

Award Ceiling: $239,000

Award Floor:

Funding Opportunity Number: RFA-HL-22-009

Purpose: The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.  The over-arching goal of this NHLBI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs.  To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: June 8, 2021

Expected Number of Awards: 6

Estimated Total Program Funding: $1,240,000

Award Ceiling: $200,000

Award Floor:

Funding Opportunity Number: RFA-CA-21-013

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for the development of innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Program, this FOA encourages applications focused on the development of novel computational, mathematical, and statistical algorithms and methods that can considerably improve acquisition, management, analysis, and dissemination of relevant data and/or knowledge. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, there must be a clear rationale for how the proposed informatics method or algorithm is novel and how it will benefit the cancer research field. Potential applicants who are interested in downstream technology development, from prototyping to hardening and adaptation, should consult the other companion FOAs listed above.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: June 8, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: RFA-CA-21-014

Purpose: The goal of this FOA is to advance cancer model systems that recapitulate human immunity in the tumor microenvironment to improve the predictivity of immuno-oncology studies. Proposed research projects must focus on recapitulation of the human immune system in their proposed cancer model using human cells or tissues to regenerate and/or recapitulate the human immune system in in vivo or in vitro immuno-oncology models in a manner that matches or exceeds representation of the human immune system achieved with murine models developed using HFT. Models derived from genetically manipulated immune systems without introduction of human immune lineage cells will not be considered responsive. The FOA will utilize the R33 Exploratory/Developmental Grants Phase II research activity code.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: June 8, 2021

Expected Number of Awards: 4

Estimated Total Program Funding: $3,600,000

Award Ceiling: $600,000

Award Floor:

Funding Opportunity Number: RFA-CA-21-015

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research field. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process must be included. Potential applicants who are interested in early-stage development or informatics resource sustainment should consult the companion FOAs listed above.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: June 8, 2021

Expected Number of Awards: 2

Estimated Total Program Funding: $3,600,000

Award Ceiling: $600,000

Award Floor:

Funding Opportunity Number: RFA-CA-21-016

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high value informatics research resources to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on sustaining operations and improving the user experience and availability of existing, widely-adopted informatics tools and resources. This is in contrast to early-stage and advanced development efforts to generate these tools and resources that are supported by companion ITCR FOAs. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, the proposed sustainment plan must provide clear justification for why the research resource should be maintained and how it has benefitted and will continue to benefit the cancer research field. In addition, mechanisms for assessing and maximizing the value of the resource to researchers and supporting collaboration and deep engagement between the resource and the targeted research community should be described.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: June 8, 2021

Expected Number of Awards: 4

Estimated Total Program Funding: $600,000

Award Ceiling: $100,000

Award Floor:

Funding Opportunity Number: RFA-CA-21-017

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI R01 research projects proposing to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating informatics methods, tools or resources developed through current or previous support from the NCI Informatics Technology for Cancer Research (ITCR) Program. Awards from this FOA are meant to spur novel collaborations and to incentivize the adoption, adaptation, and integration of these informatics technologies in support of the appropriate research communities. As a component of the NCI ITCR program, this FOA aims to promote interdisciplinary collaboration in the adoption and enhancement of innovative informatics methods, tools, and resources that enable cancer research and accelerate scientific discovery.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: June 8, 2021

Expected Number of Awards: 4

Estimated Total Program Funding: $600,000

Award Ceiling: $100,000

Award Floor:

Funding Opportunity Number: RFA-CA-21-018

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI U01 research projects. These revision applications can request support for expansion of the original scope of the parent study by incorporating informatics methods, tools or resources developed through current or previous support from the NCI Informatics Technology for Cancer Research (ITCR) Program. Awards from this FOA are meant to spur novel collaborations and to incentivize the adoption, adaptation, and integration of these informatics technologies in support of the appropriate research communities. As a component of the NCI ITCR program, this FOA aims to promote interdisciplinary collaboration in the adoption and enhancement of innovative informatics methods, tools, and resources that enable cancer research and accelerate scientific discovery.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)

Letter of Intent Due Date: 30 days prior to application due date

Proposal Due Date: June 8, 2021

Expected Number of Awards: 4

Estimated Total Program Funding: $600,000

Award Ceiling: $100,000

Award Floor:

Funding Opportunity Number: RFA-CA-21-019

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI U24 resource-related research projects. These revision applications can request support for expansion of the original scope of the parent study by incorporating informatics methods, tools or resources developed through current or previous support from the NCI Informatics Technology for Cancer Research (ITCR) Program. Awards from this FOA are meant to spur novel collaborations and to incentivize the adoption, adaptation, and integration of these informatics technologies in support of the appropriate research communities. As a component of the NCI ITCR program, this FOA aims to promote interdisciplinary collaboration in the adoption and enhancement of innovative informatics methods, tools, and resources that enable cancer research and accelerate scientific discovery.

View more details on this opportunity.

 

Department of Health and Human Services – National Institutes of Health – NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)

Proposal Due Date: June 9, 2021

Expected Number of Awards:

Estimated Total Program Funding:

Award Ceiling:

Award Floor:

Funding Opportunity Number: PAR-21-073

Purpose: The purpose of this Funding Opportunity Announcement (FOA) is to encourage institutions to propose creative and innovative institutional research career development programs which prepare clinically trained vision scientists for independent research careers.  This initiative is intended to expand and strengthen the community of clinician investigators engaged in clinical research.  Such an increase in the number of well-trained clinical researchers is necessary to achieve a pool of scientists with contemporary, multidisciplinary expertise able to leverage recent advances in ocular genetics, artificial intelligence, computational modelling, ocular therapeutics, bioengineering, and bio-behavioral research in order to enhance patient treatment and to increase scientific momentum in these fields.

This Funding Opportunity Announcement (FOA) allows appointment of Scholars proposing a separate ancillary study to an existing trial or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development. For this career development program scholars are limited to clinical trials that are mechanistic and/or minimal risk. The existing clinical trial must be a NIH-defined clinical trial that fulfills the NIH requirement for either a mechanistic or minimal risk trial. A mechanistic trial is designed to understand a biological or behavioral process, the pathophysiology of a disease, or the mechanism of action of an intervention. A minimal risk trial is one in which the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests. For this career development program, scholars are limited to clinical trials that are mechanistic and/or minimal risk. Applicants are strongly advised to consult with NEI program staff prior to submitting an application with human subjects to determine the appropriate funding opportunity.

View more details on this opportunity.

 

Department of Health and Human Services – Substance Abuse and Mental Health Services Administration – Mental Health Awareness Training

Proposal Due Date: February 5, 2021

Expected Number of Awards: 134

Estimated Total Program Funding: $16,778,013

Award Ceiling:

Award Floor:

Funding Opportunity Number: SM-21-007

Purpose: The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Mental Health Services (CMHS) is accepting applications for fiscal year (FY) 2021 Mental Health Awareness Training grants (Short Title: MHAT). The purpose of this program is to: (1) train individuals (e.g., school personnel, emergency first responders, law enforcement, veterans, armed services members and their families) to recognize the signs and symptoms of mental disorders, particularly serious mental illness (SMI) and/or serious emotional disturbance (SED); (2) establish linkages with school- and/or community-based mental health agencies to refer individuals with the signs or symptoms of mental illness to appropriate services; (3) train emergency services personnel, veterans, law enforcement, fire department personnel, and others to identify persons with a mental disorder and employ crisis de-escalation techniques; and (4) educate individuals about resources that are available in the community for individuals with a mental disorder. It is expected that this program will prepare and train others on how to appropriately and safely respond to individuals with mental disorders, particularly individuals with SMI and/or SED.

View more details on this opportunity.

 

Department of Health and Human Services – Substance Abuse and Mental Health Services Administration – Grants for Expansion and Sustainability of the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances

Proposal Due Date: February 5, 2021

Expected Number of Awards: 15

Estimated Total Program Funding: $15,030,147

Award Ceiling:

Award Floor:

Funding Opportunity Number: SM-21-007

Purpose: The Substance Abuse and Mental Health Services Administration, Center for Mental Health Services (CMHS), is accepting applications for fiscal year (FY) 2021 Grants for Expansion and Sustainability of the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances (Short title: System of Care (SOC) Expansion and Sustainability Grants). The purpose of this program is to improve the mental health outcomes for children and youth, birth through age 21, with serious emotional disturbances (SED), and their families. This program will support the implementation, expansion, and integration of the SOC approach by creating sustainable infrastructure and services that are required as part of the Comprehensive Community Mental Health Services for Children and their Families Program (also known as the Children’s Mental Health Initiative or CMHI).

View more details on this opportunity.